Objectives: Cardiovascular disease is the leading cause of mortality in patients with systemic lupus erythematosus. Therefore, using diet to control blood lipid levels and modify cardiovascular disease risk could be a promising therapeutic strategy to control disease symptoms. The primary objective of this study was to learn about systemic lupus erythematosus patient experiences with diet, including their opinion on considering diet as a therapeutic option. The secondary objective was to obtain this information in a cost-and time-effective manner. Methods: A lay summary and a 15-question diet-based online survey were publicly available for 3 weeks. Social media was used to promote the survey through relevant charities, hospitals and research groups. Results: A total of 300 responses were received, 284 from patients with systemic lupus erythematosus. Patients reported that there was a lack of clinical counselling regarding diet, with only 24% stating their doctor had spoken to them about diet. Despite this, 100% of patients stated they would change their diet if they knew it would help their symptoms and 83% would take part in a future diet-based clinical trial. Text analysis of patient research suggestions identified a particular interest in using diet to treat fatigue and manage disease flares. Conclusions: This project successfully gathered patient information regarding diet and systemic lupus erythematosus over a short timeframe using an anonymous social media platform. The survey provided evidence that patients support further research and potential diet intervention studies investigating the effect of diet on the symptoms of systemic lupus erythematosus. Lupus (2019) 28, 755-763.
Introduction
Systemic lupus erythematosus (lupus) is a complex autoimmune disorder characterised by chronic inflammation, multiple organ damage and increased risk of cardiovascular disease (CVD); CVD is the leading cause of mortality for patients. [1] [2] [3] [4] Our research and other published work have identified a therapeutic opportunity for the use of diet in controlling the symptoms of lupus and CVD risk through manipulation of serum blood lipid (fat) levels. [5] [6] [7] [8] Involving patients and other stakeholders in clinical research through Patient and Public Involvement and Engagement (PPIE) strategies is an essential ethical mandate for clinical research. [9] [10] [11] However, published data are difficult to find regarding patient opinion about basic science research. It is of huge importance to relate research to patient experience; patients learn about the research being carried out regarding their disease and we as researchers learn how the work can impact the patient community. 12, 13 In addition, patient engagement provides valuable insight into how patients view future therapeutic intervention ideas. A recent study by McDonnell et al. demonstrated a time-and cost-effective approach to PPIE that addressed these issues. Their online survey acquired 520 patient responses over a 3-week period through social media promotion to assess which research topics are of the most interest to patients with lupus and/ or antiphospholipid syndrome (APS).
In this study, an online survey approach was taken to gather opinion from patients with lupus about their experiences with diet and to ask them their priorities regarding research into lupus in general. A secondary objective was to validate the study carried out by McDonnell et al. showing that PPIE using online platforms can be a simple, valuable and time-and cost-effective approach. 14 
Methods

Study design
An anonymous survey was established consisting of a lay research summary and a brief description of the survey. The aim was to capture as many responses in the shortest time possible to facilitate a cost-and time-effective process. The survey consisted of 15 questions focused around diet in patients with lupus ( Instagram. An initial question asking patients to self-report that they had lupus was put in place to stratify responses. Multiple submissions from the same participant were prevented.
Analysis of responses
Analysis of the data extracted from SurveyMonkey was carried out using Microsoft Excel 2010 and GraphPad Prism 6. 'Wordcloud' software (https:// www.wordclouds.com/) was used to produce a wordmap from patients' free text.
Results
Online platforms provide substantial responses to PPIE surveys across multiple age ranges A survey to obtain patient opinion on the use of diet as a therapy in lupus and information on patient experiences with diet and disease was established (Table 1) . After 3 weeks of social media promotion by various charities, 300 responses were received ( Figure 1) .
A gradual increase in survey responses was observed through the use of Twitter to publicise the survey link across the lupus community. This was done through the help of charities such as Arthritis Research UK and the Lupus Research Alliance (a US-based association), awareness groups including Lupus Science & Medicine and Dr Rheum, and university-related groups such as UCL Faculty of Medical Science, APS research, Young People United and UCL Hospital (UCHL)/UCL National Institute for Health Facebook page and to their community forum, which resulted in the biggest increase in responses to a total of 300 by the end of week 3. Of the 300 respondents, 284 had a self-reported lupus diagnosis. Based on the style of responses from the other 16, it was possible they had another autoimmune disease; however, these respondents were excluded from further analysis. The majority of respondents (98.59%) were female ( Table 2) . There was a fairly even spread of survey responses across age groups between 18 and 64 years ( Table 2) . Fewer responses were obtained from patients younger than 24 and older than 65, whereas patients in the 45-54 age bracket provided most responses (30.63%).
Patients thought diet could be important in controlling lupus symptoms
Patients considered diet could be important in controlling symptoms of lupus (average score 5.88/10) (Figure 2(a) ). Furthermore, respondents thought it would be valuable to know how diet influences disease symptoms (average score 8.47/10) (Figure 2(b) ). Despite this interest, only 24.11% of patients had ever discussed diet with their doctors in relation to their disease (Figure 2(c) ). Almost all respondents (99.29%) felt it was important for doctors to know whether diet could influence disease (Figure 2(d) ). In addition, most patients revealed they would change their diet if they knew it would help their disease symptoms; 85.92% would alter their diet and a further 13.73% expressed they would alter their diet if recommended by their doctor (Figure 2(e) ). Importantly, most patients surveyed (82.62%) would be interested in taking part in Figure 1 Cumulative response number over the 3-week survey period. Cumulative number of responses over the 3 weeks that the survey was publicly accessible. Social media promotional help from various charities is highlighted with a particular acknowledgement to Lupus UK, who helped greatly with survey distribution. a diet trial in the future with the primary outcome to reduce disease symptoms (Figure 2(f) ). Thus, patients were interested in finding out about how diet could influence their disease and would be willing to change their diet to help control their disease symptoms. No obvious difference in survey responses was seen across different age brackets apart from a possible increase in dietary counselling for younger patient ages 12-17 ( Figure 2(g) ).
Some lupus patients associated diet with improved disease symptoms
When asked whether they had tried dieting during the course of their disease, 35.82% of patients had not (Figure 3(a) ). Of those who had, the most popular diets were Slimming World, Weight Watchers, paleo and Atkins. The majority of patients, however, selected 'other'; here the two most popular diets were gluten free and low carbohydrate (Table S1 ). The most common reason for starting a diet was to lose weight (48.61%), followed by improve their disease (26.53%) and to look good (9.80%). Notably, only 8.16% of patients started their diet due to doctor's recommendation (Figure 3(b) ).
The most popular free text response under the 'other' option was 'to get healthier' and 'for allergies' (Table S1 ). From those that had been on a diet, only 7.06% of patients said they did not feel a benefit; whereas 43.87% lost weight and 22% considered their disease symptoms and mood had improved as a result of their diet. Vegan and low-gluten and low-sugar diets provided the highest percentage of responses for improved disease symptoms (Figure 3(d) ). Some respondents (21.19%) felt happier in their image and 14.5% had improved fitness (Figure 3(c) ). Additional benefits stated under the 'other' option were reduced fatigue and pain reported by 9% patients (Table S1 ). Of those that had been on a diet, only 27.24% of patients used an app to monitor it (Figure 3(e) ).
As the management of lupus often involves prescribed dietary supplements, we asked about the supplements these patients were taking. We found that 70.03% of these patients take dietary supplements (Figure 3(f) ), the most popular being vitamin D (29%), iron (13%), multivitamins (12%) and fish oils (7%) ( Table S1 ).
What should we be researching?
Finally, an optional free-text opportunity was included where patients were asked to state research questions they feel should be investigated with regard to diet in lupus. Almost half of the patients left a response to this question (125 out of the total 284, 44%). The analysis of these results was carried out using wordmap software to visualise the most commonly mentioned ideas (Figure 4) . The top responses included diet, foods, symptoms, lupus, fatigue and flare ups and other responses such as supplements, gut microbiome, dairy, stress and oils were also stated (Table S2) . Patients also expressed an interest in how therapeutics such as corticosteroids influenced their diet and weight (Table S3) .
Discussion
This survey revealed three key discoveries: first, patients thought it was important for them and their doctors to know how diet can influence lupus and that they would be interested in trying diet as a therapeutic option; despite this, we found that very few doctors had discussed diet with their patients. Second, a large number of patients had never been on a diet; however, of those that had, many felt it had improved their disease symptoms. Finally, this survey confirmed it is possible to obtain fast, cost-effective patient opinions online through social media promotion and provided a template for future studies.
As expected, the majority of respondents were female, reflecting the sex bias of the disease. 15 However, the even spread of responses across the age groups between 18 and 64 was surprising considering social media is believed to be more popular amongst the younger age groups; in 2017 96% of people aged 16-24 used social media platforms, whereas this was only 68% for those aged 45-54 years (www.ons.gov.uk). It was of little surprise that a lack of responses came from under 18 s and over 64 s as this is likely due to lack of access to or interest in social media as well as a known decrease in the incidence of lupus diagnosis in these age groups. 16 Therefore, this social media-based approach for gaining public responses for research may not be as beneficial for common diseases in young children and older people.
Only 25% of patients who responded had discussed diet with their doctors, although most thought that diet could be important in their disease and 100% of patients said they would change their diet if they knew it would help their disease symptoms. This reflects a general interest of patients to engage with strategies where they have more control over the management of their disease. 17 Furthermore, this positive attitude towards diet highlights the potential for recruiting and maintaining good compliance in any future trials focused in this area.
Indeed, two-thirds of respondents had undertaken a diet previously, although only 22% of these patients reported a notable improvement in disease symptoms. This observation could be confused by the wide range of diets attempted; Weight Watchers and Slimming World were the most popular. Interestingly, vegan and low-gluten and low-sugar diets appeared to improve disease symptoms the most. In addition to diets, we inquired about dietary supplements. It was no surprise to see that 70% of patients took supplements as common symptoms of lupus include vitamin D and iron deficiency; Table S2 and S3. however, only 7% of the patients taking supplements took fish oils, known to have health benefits, 19 modify blood lipid profiles 20, 21 and reduce cardiovascular risk, which is high in lupus patients. 22 The results of this survey show that patients with lupus are interested in research. Answers from the 'free-text box' section of the survey revealed several common concerns, such as flare-ups and fatigue. Between 40% and 50% of adults with lupus are classified as obese [23] [24] [25] [26] and patients with obesity have increased fatigue and disease activity. 27 Davies et al. conducted a diet trial in lupus comparing 23 patients on a low glycaemic index diet to a low-calorie diet for 6 weeks. 28 Both diets were effective in reducing fatigue and helped patients to lose weight. In addition, both diets were well tolerated, with mild adverse effects including no increase in disease activity. This supports a role for diet in controlling disease symptoms and demonstrates how a research-and patient-driven idea can provide beneficial results. Importantly, patients raised concerns around the effects of current lupus therapeutics on diet and weight gain. This is particularly important for lipid metabolism as studies have highlighted how prolonged use of corticosteroids can cause dyslipidaemia, something that would need to be considered in a clinical trial related to using diet to modify lipid metabolism. 29, 30 PPIE can be a time-consuming and costly experience and studies have attempted to address this issue to improve and accelerate translational research. 31, 32 For example, Elwyn et al. used postal distribution of a survey to 1146 participants with asthma, open to responses for 3 months, and a 3-week online post on a relevant charity website. A total of 370 responses were received with a cost of £29,000. 33 In contrast, we gathered 300 responses, with minimal cost (£35) from a 3-week online survey using the power of charity-based and individual social media pages for promotion.
There have been few previous attempts to use this approach for PPIE in basic science research. One example of its effectiveness, however, was demonstrated by McDonnell et al. where a similar number of responses were gathered over a 3-week period to assess topics that were of interest to a specific patient population. 14 Limitations of this study include potential selection bias; survey responders may complete the survey based on a prior interest in the research topic. In addition, responses gathered through this type of survey can only be obtained from patients with access to social media and/or the internet. This could add bias towards responses from younger patients, although data obtained here suggests otherwise. One possibility is that the lay summary was too long and complicated for a younger audience and that 'lupus' was not in the title; this could have accounted for the relatively lower than expected number of younger respondents. Future studies could benefit from feedback from a wider range of age groups. Another limitation to this approach is the language barrier; however, the lay summary and questions could be translated in future. Finally, this approach leaves no opportunity for follow-up questions as responses are anonymous.
In summary, this survey identified that patients with lupus are interested in finding out whether diet could influence their disease. We also identified that there is a lack of knowledge and education about diet in the responders and that most patients had not talked to their doctors about diet. Many patients had tried various diets but very few controlled trials have been performed to inform patient choices. 34 This survey identified that patients would be enthusiastic in supporting research and diet intervention studies with close monitoring of disease symptoms and cardiovascular risk. In future, more focused face-to-face discussions with patients could help to optimise clinical trial design and determine the feasibility of potential diet-focused therapeutic interventions. Thus, this survey provides evidence of patient support for further research into the effects of diet on the symptoms of lupus.
Key messages
. Lupus patients are interested in diet as a therapeutic option. . There is a lack of communication between doctors and their patients regarding diet. . Social media is a time-and cost-efficient method for patient and public engagement and involvement.
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